HER2 Support Group Forums - View Single Post - FDA approves Halaven therapy for metastatic late-stage breast cancer

News · 11-15-2010, 11:49 PM

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease.

More...

11-15-2010, 11:49 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,004	FDA approves Halaven therapy for metastatic late-stage breast cancer The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease. More...